Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle.
about
Genome-wide interrogation of Mammalian stem cell fate determinants by nested chromosome deletionsMicroRNA-302 increases reprogramming efficiency via repression of NR2F2.DNA damage causes TP53-dependent coupling of self-renewal and senescence pathways in embryonal carcinoma cellsExploiting the power of LINE-1 retrotransposon mutagenesis for identification of genes involved in embryonic stem cell differentiation.Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal.Tissue polarity-dependent control of mammary epithelial homeostasis and cancer development: an epigenetic perspective.Transcripts that associate with the RNA binding protein, DEAD-END (DND1), in embryonic stem (ES) cellsMybl2, downregulated during colon epithelial cell maturation, is suppressed by miR-365.Differential roles of Sall4 isoforms in embryonic stem cell pluripotencyThe B-MYB transcriptional network guides cell cycle progression and fate decisions to sustain self-renewal and the identity of pluripotent stem cells.MYBL2, a link between proliferation and differentiation in maturing colon epithelial cells.Histone deacetylase regulates high mobility group A2-targeting microRNAs in human cord blood-derived multipotent stem cell aging.Towards a dynamical network view of brain ischemia and reperfusion. Part II: a post-ischemic neuronal state spaceThe ciliary proteins Meckelin and Jouberin are required for retinoic acid-dependent neural differentiation of mouse embryonic stem cells.Tuberous sclerosis complex and Myc coordinate the growth and division of Drosophila intestinal stem cells.Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placentaNucleolin maintains embryonic stem cell self-renewal by suppression of p53 protein-dependent pathway.Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biologyTransient inhibition of cell proliferation does not compromise self-renewal of mouse embryonic stem cellsAn analysis and validation pipeline for large-scale RNAi-based screens.Dclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewalThe abbreviated pluripotent cell cycle.Epigenetic Modulation of Stem Cells in Neurodevelopment: The Role of Methylation and Acetylation.Mechanisms Regulating Stemness and Differentiation in Embryonal Carcinoma Cells.Regulation of cellular chromatin state: insights from quiescence and differentiation.The use of induced pluripotent stem cells in drug development.Banf1 is required to maintain the self-renewal of both mouse and human embryonic stem cells.The function of e-cadherin in stem cell pluripotency and self-renewalPhenotypic Screen Identifies a Small Molecule Modulating ERK2 and Promoting Stem Cell Proliferation.Mouse embryonic stem cells have increased capacity for replication fork restart driven by the specific Filia-Floped protein complex.Combining competition assays with genetic complementation strategies to dissect mouse embryonic stem cell self-renewal and pluripotency.JMJD5 regulates cell cycle and pluripotency in human embryonic stem cells.Pluripotency of human embryonic and induced pluripotent stem cells for cardiac and vascular regeneration.Omega 3 polyunsaturated fatty acids inhibit cell proliferation by regulating cell cycle in fad3b transgenic mouse embryonic stem cells
P2860
Q21144967-584C5CF8-FF7A-4A60-B804-0AAF28B55205Q30535757-8600397F-669E-4627-920D-D88EDF440467Q30537160-A9070513-6214-4E36-9259-9A5B9E2CFE63Q33561315-4A3F23EC-1A6E-413A-98D7-4BB066457921Q33590178-D192CF50-A82B-47E3-930C-D57B81BD456EQ33817720-31F05304-21F5-4341-A5CD-706EDA45BE48Q33996172-C4F332B8-CA45-457B-A113-C9FAE8031495Q34198613-CBC6496F-972B-4B06-9E8F-6EF15CFB9316Q34290954-D6426ED9-ED5A-4005-BC23-D76F4983BA9CQ34398856-EA33E118-2B1B-4324-A916-C81D6C0E2CB0Q34451432-EBBC161B-2665-46D9-9D14-016EB7182986Q34468938-A0DF39A6-320B-4628-A544-96D97C7E2785Q34502787-29F216B3-E5EA-4B5B-8DB5-048B6D997DFDQ35166357-B817C7A1-5DCC-481C-A1BD-F48A1F36197FQ35196044-B2DFE083-5F61-4E64-9BD8-8AC9DECA0270Q35488673-5E938AC0-CC8E-4315-AC75-26995486A635Q35604698-B3DEF1B0-6689-495F-BF9D-3DCCD97A93E5Q35848944-8A0C96FA-C584-479C-856E-0689BD312852Q36129237-C7EFBC63-F2F4-488F-AD10-CD393C71071AQ36537190-7B7CF838-6F7B-4018-AE43-A1D9C0092F34Q36544448-18A89C39-0605-4DD5-B52C-3E5570662CFDQ36886887-3C125853-DE0B-4517-89CC-65B7C7B7B90EQ37627145-BC04A113-F142-447D-A88A-BE06122E7D79Q37714726-E655FB9B-02E8-40ED-8216-18B58E17E4D6Q37769115-E52F5217-C434-4D49-8145-0126D498593DQ37856714-58553221-04AB-4BBB-B836-C2358D09E7CDQ39507999-7FA82D11-0314-4856-B2EF-EEAD467619AFQ41956122-4F9F4D7B-B375-4EB6-90D8-4910CBA6A338Q45793442-7FE1D2E5-B185-418E-863F-BFE58ABA4F75Q47417363-792CBF44-CEC9-4CEA-81F7-B78F3F57A3ECQ51800437-04D05D78-F387-44E3-9E57-9566F3471A8AQ53057180-FF448C26-E6E4-4794-9CB0-8B266B8C07E9Q55342040-10356ECB-4DF3-41B9-983E-9963C6D1C380Q58757922-A615FF18-5762-477F-B7C2-C16B77111292
P2860
Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Stem cell pluripotency: a cell ...... eckpoint deficient cell cycle.
@ast
Stem cell pluripotency: a cell ...... eckpoint deficient cell cycle.
@en
type
label
Stem cell pluripotency: a cell ...... eckpoint deficient cell cycle.
@ast
Stem cell pluripotency: a cell ...... eckpoint deficient cell cycle.
@en
prefLabel
Stem cell pluripotency: a cell ...... eckpoint deficient cell cycle.
@ast
Stem cell pluripotency: a cell ...... eckpoint deficient cell cycle.
@en
P2860
P356
P1476
Stem cell pluripotency: a cell ...... eckpoint deficient cell cycle.
@en
P2093
Kenneth R Boheler
P2860
P356
10.1002/JCP.21866
P577
2009-10-01T00:00:00Z